These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16790944)

  • 41. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
    Pina G; Dubois S; Murat A; Berger N; Niccoli P; Peix JL; Cohen R; Guillausseau C; Charrie A; Chabre O; Cornu C; Borson-Chazot F; Rohmer V;
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):358-64. PubMed ID: 22913268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
    Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
    Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal.
    Faggiano A; Milone F; Ramundo V; Chiofalo MG; Ventre I; Giannattasio R; Severino R; Lombardi G; Colao A; Pezzullo L
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E32-6. PubMed ID: 20534767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of an immunoassay for calcitonin].
    Sylla Niang M; Lombardo F; Schlumberger M; Bidart JM
    Dakar Med; 2008; 53(1):76-83. PubMed ID: 19102121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
    Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
    Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.
    Toledo SP; Lourenço DM; Santos MA; Tavares MR; Toledo RA; Correia-Deur JE
    Clinics (Sao Paulo); 2009; 64(7):699-706. PubMed ID: 19606248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcome of reoperations for medullary thyroid carcinoma.
    Fialkowski E; DeBenedetti M; Moley J
    World J Surg; 2008 May; 32(5):754-65. PubMed ID: 18188643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential absence of prognostic implications of severe preoperative hypercalcitoninemia in medullary thyroid carcinoma.
    Zangeneh F; Gharib H; Goellner JR; Kao PC
    Endocr Pract; 2003; 9(4):284-9. PubMed ID: 14561572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test".
    Niederle MB; Scheuba C; Gessl A; Li S; Koperek O; Bieglmayer C; Riss P; Selberherr A; Niederle B
    Biochem Med (Zagreb); 2018 Oct; 28(3):030710. PubMed ID: 30429678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer.
    Allelein S; Ehlers M; Morneau C; Schwartz K; Goretzki PE; Seppel T; Feldkamp J; Krieg A; Knoefel WT; Kuebart A; Haase M; Dringenberg T; Schmid C; Schott M
    Horm Metab Res; 2018 Jan; 50(1):23-28. PubMed ID: 29169190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical management of sporadic medullary thyroid cancer.
    Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
    J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
    Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
    Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.
    Kwon H; Kim WG; Choi YM; Jang EK; Jeon MJ; Song DE; Baek JH; Ryu JS; Hong SJ; Kim TY; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):598-603. PubMed ID: 25041034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
    Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
    J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of circulating calcitonin: analytical aspects.
    Martinetti A; Seregni E; Ferrari L; Pallotti F; Aliberti G; Coliva A; Fracassi S; Bombardieri E
    Tumori; 2003; 89(5):566-8. PubMed ID: 14870789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients.
    Chambon G; Alovisetti C; Idoux-Louche C; Reynaud C; Rodier M; Guedj AM; Chapuis H; Lallemant JG; Lallemant B
    J Clin Endocrinol Metab; 2011 Jan; 96(1):75-81. PubMed ID: 20881258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of preoperative serum calcitonin in patients with nodular thyroid disease without suspicious history or cytology for medullary thyroid carcinoma.
    Rosário PW; Penna GC; Brandão K; Souza BÉ
    Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):312-6. PubMed ID: 23828436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
    Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.